C-reactive protein-to-lymphocyte ratio is a reliable marker in patients with COVID-19 infection: the CLEAR COVID study
- 2022, Volume 90 - Number 5
- Published: December 31, 1969
C-reactive protein-to-lymphocyte ratio is a reliable marker in patients with COVID-19 infection: the CLEAR COVID study
Muhammed E. Demirkol 1, Satilmis Bilgin 1, Gizem Kahveci 1, Ozge Kurtkulagi 1, Burcin M. Atak Tel 1, Tuba T. Duman 1, Gulali Aktas 1
1 Department of Internal Medicine, AbantIzzetBaysal University Hospital, Golkoy, Bolu, Turkey
Muhammed E. Demirkol, Satilmis Bilgin, Gizem Kahveci, Ozge Kurtkulagi, Burcin M. Atak Tel, Tuba T. Duman, Gulali Aktas
La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.
*Correspondence: Burcin M. Atak Tel, Email not available
Abstract
Full content available in the PDF
Keywords: COVID-19. Mortality. Inflammation. C-reactive protein-to-lymphocyte ratio.
